Air purification manufacturer Fellowes’ AeraMax Pro AM3 and AM4 devices have been proven to be effective in eliminating the virus responsible for Covid-19.
A study at the University of Genoa School of Medicine found that the Fellowes air purifiers neutralised the airborne viral load of SARS-CoV-2 entirely and were able to remove 99.9999 per cent of the aerosolised SARS-CoV-2 through a single pass of the purifier.
“The AeraMax Pro AM3 and 4 air purifiers were evaluated in extreme laboratory operating conditions, certainly much more critical and difficult than the real environmental situation,” said Dr. Alberto Izzotti at the University of Genoa School of Medicine department of experimental medicine.
“This situation was purposely designed since it is necessary to test the effectiveness of similar sanitising devices in critical conditions to guarantee their effective performance. Despite the extreme conditions used, the Fellowes air purification technology was able to neutralise the airborne viral load,” he added.
The result comes following the manufacturer’s recent studies released in early 2021, where its AeraMax Pro products showed a 99.99 per cent airborne reduction of a coronavirus surrogate and 99.9 per cent removal of the H1N1 flu virus, commonly known as swine flu.
“It is now widely accepted by the scientific community that airborne transmission of aerosol droplets is the primary cause of the transmission of COVID-19,” said Darryl Brunt, UK and Ireland lead at Fellowes Brands.
“We are thrilled that this latest study proves how effective our unique Aeramax Pro technology is in helping to reduce the transmission of harmful viruses that cause deadly diseases such as Covid-19,” he added.
